Innovent Biologics Inc
OTC:IVBXF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Innovent Biologics Inc
OTC:IVBXF
|
CN |
|
G
|
Glorious Sun Enterprises Ltd
XMUN:GLV
|
HK |
|
C
|
CASI Pharmaceuticals Inc
F:ENMN
|
US |
|
Magna Mining Inc
F:8YD
|
CA |
|
Zug Estates Holding AG
F:ZEE
|
CH |
|
Crimson Tide PLC
F:EYM0
|
UK |
|
S
|
Stoneridge Inc
F:2GX
|
US |
|
B
|
BAVARIA Industries Group AG
SWB:B8A
|
DE |
|
K
|
K Wah International Holdings Ltd
XBER:KW2
|
HK |
|
Clean Air Metals Inc
F:CKU
|
CA |
|
T
|
Tachi-S Co Ltd
OTC:TCISF
|
JP |
|
B
|
Beijing North Star Co Ltd
SWB:BJ3
|
CN |
Shareholder Yield
Current shareholder yield for 
IVBXF is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
IVBXF Price
Innovent Biologics Inc
| Average Annual Return | -15.72% |
| Standard Deviation of Annual Returns | 25.63% |
| Max Drawdown | -78% |
| Market Capitalization | 178B USD |
| Shares Outstanding | 1 628 020 000 |
| Percentage of Shares Shorted |
N/A
|
